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Abstract 
BACKGROUND: Cancer is one of the causes of morbidity and mortality worldwide. Breast cancer is one of the 
most common types of cancer in Indonesia. Failures that often occur in the treatment of cancer primarily through 
chemotherapy, synthetic drugs that have side effects include anemia, alopecia, cardiotoxic and hepatotoxic due to 
low anti-cancer selectivity and unclear carcinogenesis process. Cyperus rotundus L. rhizome is one of the 
medicinal plants that potential enough to be developed as an anticancer agent.  
AIM: The aim of this study was to anticancer activity n-hexane fraction Cyperus rotundus L. rhizomes to breast 
cancer MCF-7 cell line in vitro. 
METHODS: Cyperus rutundus L. rhizomes powder was extracted ethanol by percolation then fractionated with n-
hexane. Phytochemical screening was then carried out. The cytotoxic activity of the n-hexane fraction was 
determined by observing this extract on MCF-7 cells using the (3- (4,5-dimethylimidazole-2-il) -2,5-diphenyl 
tetrazolium bromide) (MTT). Selectivity index (IS) of normal cells (Vero cells). Cell cycle and apoptosis induction 
were analyzed by flow cytometry. 
RESULTS: The result showed that the fraction n-hexane Cyperus rutundus L. rhizome has anticancer activity 
against breast cancer MCF-7 cells with accumulation cell cycle in the G0-G1 phase and through induction of 
apoptosis.  
CONCLUSION: The n-hexane fraction Cyperus rotundus L. rhizome has potent anticancer activity. 
 
 
 
 
 
 
Introduction 
 
MCF-7 cells are breast cancer cells that 
express estrogen receptors (ER+) and originate from 
pleural effusion breast adenocarcinoma a 69-year-old 
female patient, blood type O. These cells express 
estrogen receptor alpha (ER-α), are resistant 
doxorubicin [1].  
The results of GC/MS analysis showed that 
the main components identified from the Cyperus 
rotundus root essential oils such as α-Cyperone 
(11.0%), myrtenol (7.9%), caryophyllene oxide (5.4%), 
β-pinene (5.3%), Sesquiterpenes (41.2 %) and 
oxygenated monoterpenes (13.8 %) [2], [3]. 
Cyperus rotundus L. is known to have 
cytotoxic effects on some cancer cells, such as 
leukemia cells K562 and L1210 [4], lymphoma cells of 
L5178 mice [5], HeLa cells and SiHa cells in cervical 
cancer [6], Ehrlich’s ascites carcinoma breast cancer 
[7], and KB oral cancer [8].The essential oil potent 
cytotoxic activities against colon (HCT-116), 
hepatocellular (Hep G-2) and breast (MCF-7) human 
cancer cell lines with IC50 of 1.06, 1.17 and 2.22 
μg/mL, respectively [3].  
Therefore this study is to prove whether the 
rhizome of Cyperus roundus L.fractionated with n-
hexane has the potential as a breast anticancer 
performed by cytotoxic testing, selectivity index (IS), 
induction apoptosis in MCF-7 cells. So, from the test 
series above the rhizome of Cyperus rotundus L. can 
be used as one of the anticancer drugs. 
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Material and Methods 
 
The materials that used in this study were 
MCF-7 (Michigan Cancer Foundation-7) cell and Vero 
cell culture collection of the Laboratory Parasitology 
UGM Faculty of Medicine obtained from Prof. Tatsuo 
Takeya, Japan, DMEM (Dulbecco’s Modified Eagle 
Medium). EDTA Trypsin 0.25%, MTT Reagent (3- 
(4,5-dimethylimidazole-2-il) -2,5-diphenyl tetrazolium 
bromide, DMSO (Dimethyl Sulfoxide) Stopper reagent 
SDS (sodium dodecyl sulfate and Phosphate Buffer 
Saline). The main ingredients used rhizomes of 
Cyperus rotundus Linn. obtained from the area named 
Blang Kolak 1 Village, Bebesen District, Nanggroe 
Aceh Darussalam Province, Indonesia. The sample 
was identified at the Herbarium Medanense Institute 
(MEDA) at the Universitas Sumatera Utara. 
Authentification number 1941 / MEDA / 2018. The 
dried powder was percolation used ethanol 96% then 
fraction n-hexane the obtained percolation was 
evaporated and freeze-dried [9]. 
MCF-7 and vero cell 5 x 10
3 
/ well was 
implanted into 96-well plate and incubated at 37°C in 
a 5% CO2 incubator for 24 hours. Added with various 
concentrations of the n-hexane fraction Cyperus 
rotundus L. with 5 variation concentration (500, 
250,125, 62,5, and 31,25 µg/mL). Then added 100 mL 
of MTT reagent concentration (0.5 mg/ml) in DMEM 
into each well. Then incubated at 37°C again for 3 
hours until formazan is formed. The cell condition 
observation by using microscope. If formazan is 
formed clearly, a 10% SDS stopper is added in 0.1 N 
HCl. After that, the plate is again wrapped in paper or 
aluminum foil and incubated in a dark place overnight. 
Absorption is read by ELISA reader at λ 595 nm. 
MCF-7 cell line was implanted in six wells, 5 × 
10
5 
cells/wells. Microplate using coverslips and 
incubated in 5% CO2incubator for 24 hours, then for 
24 hours. Cycle cell and apoptosis assay were 
performed two concentrations (
1
/10 IC50 and ½ IC50) n-
hexane fraction Cyperus rotundus. Then re-incubated 
for 24 hours. For cell cycle testing, propidium 
iodidewhile apoptosis testing added Annexin V and 
propidium iodide. Then it is measured by a 
flowcytometer [10]. 
Cytotoxic activity was expressed by IC50, 
namely: concentration which caused the death of 50% 
of the cell population analyzed using SPSS 21 probit 
analysis with a significance of 0.05 [11]. 
 
 
Results  
 
Based on the calculation above, the results of 
the IC50 n-hexane fraction Cyperus rotundus L. was 
120.819 µg/mL and selectivity index value 1.831. 
The result of accumulation occurs of cycle 
cells, as can be seen in Figure 1 and Table 1. 
 
Figure 1: Cycle Cell nHFCR with various concentrations: A) cell 
control; B) ½ IC50; C) 
1
/10 IC50 
 
 Cell cycle analysis is carried out in the cell 
cycle phase where the accumulation occurs in each 
treatment. The control group showed MCF-7 cells in 
the G0-G1, S and G2-M phases respectively 65.48%, 
18.31% and 16.65%. After administration of ½ IC50, 
there was an increase in cell accumulation in the G0-
G1 phase to 8.58% while in the S and G2-M phases 
there was a 7.1% and 1.6% decrease in cell 
accumulation. 
Table 1: Percentage of accumulation in each phase in the cell 
cycle 
Treatment  Concentration 
Phase in the cell cycle (%) 
G0-G1 S G2-M 
Control - 65.48 28.31 16.65 
nHFRT ½ IC50 61.375 74.06 11.21 15.03 
nHFRT 
1
/10 IC50 12.27 72.48 15.76 12.13 
nHFCR: n-Hexane fraction Cyperus rotundus. 
 
The same thing was shown in the treatment 
with a concentration of 
1
/10 IC50 where the G0-G1 
phase there was an increase in cell accumulation 
7.00% while the phase of S and G2-M phases 
decreased cell accumulation 2.55% and 4.52%. The 
change is related to a concentration. However, overall 
it can be concluded that the cell cycle inhibition 
mechanism in the G0-G1 phase. 
The result of Induction apoptosis can be seen 
in Figure 2 and Table 2. 
 
Figure 2: Results of Apoptosis Analysis nHFCR with various 
concentrations: A) cell control; B) ½ IC50; C) 
1
/10 IC50  
 
 In MCF-7 cells given ½ IC50, the percentage 
of cells experiencing initial apoptosis (2.14%) was 
seen; The 
1
/10 IC50 (7.90%) and compared the control 
(1.64%). Seen the 
1
/10 IC50 increases of cells 
undergoing initial apoptosis compared to controls. The 
percentage of cells undergoing final apoptosis (initial 
necrosis) also increased in the administration of ½ 
IC50 (2.93%). 
(а)                               (b) (c)
(a)                                 (b) (c)
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Table 2: The result of apoptosis analysis for cell MCF-7 
Treatment 
Concentrate 
µg/mL 
% 
LL LR UR UL 
Control - 90.25 1.64 0.62 7.49 
nHFCR½ IC50 61.375 70.34 2.14 2.93 24.61 
nHFCR
1
/10 IC50 12.275 68.06 7.09 4.79 19.25 
Where: Bottom left (LL) = living cell; Bottom right (LR) = initial apoptotic cells; Upper right 
(UR) = late apoptotic cells and initial necrosis; Upper left (UL) = cell necrosis. 
 
The 
1
/10 IC50 (4.79%) was compared with the 
control (0.62%). Cells that experienced late necrosis 
in MCF-7 cells were given ½ IC50 (24.61%), 
1
/10 IC50 
(19.25%) shows that the percentage of necrosis 
increased compared to controls (7.49%). 
 
 
Discussion 
 
N-hexane fraction Cyperus rotundus L. active 
as an anticancer because an extract is considered 
active if it has an IC50 value of ≤ 100 μg/mL [12]. 
However, an IC50 extract value of 100-500 μg/mL can 
still be developed as an anticancer with a moderate 
classification [13]. It can be said that the n-hexane 
fraction has cytotoxic activity against MCF-7 breast 
cancer cells and affects normal cell growth (Vero 
cells). 
Inhibition of the G0-G1 cycle allows apoptosis 
to occur, so there is no activation of CDK4 and CDK6 
which results in inhibition of phosphorylation of pRb 
(protein retinoblastoma), unphosphorylated Rb binds 
to the transcription factor E2F binds DNA and inhibits 
gene transcription whose products are required for the 
phase S cell cycle so that cells are held in phase G1 
or G1 arrest occurs [14]. The cessation of the cell 
cycle in the G0-G1 phase gives the cell a chance to 
repair damaged DNA and provide an opportunity for 
damaged cells to be recognized and then proceed 
with the apoptosis process. Check point control is very 
important to maintain genomic stability. The error will 
pass the cell to breed even though there is DNA 
damage, incomplete replication, the chromosome is 
not completely separated it will produce genetic 
damage. This is called cancer. Therefore, the process 
of cell cycle regulation can play a role in cancer 
prevention [15]. 
The n-hexane fraction Cyperus rotundus L. 
shows positive activity in apoptosis by flow cytometry 
method using Annexin V. The principle of Annexin V 
labeling is staining on phosphatidylserines (PS) found 
on the outer membrane of the cell. Early apoptotic 
cells express PS on the outer plasma membrane. PS 
can be colored by annexin V label. Cells that undergo 
final apoptosis and cell necrosis will lose their cell 
membrane integrity and are permeable to annexin V 
dyes. The working mechanism of the n-hexane 
fraction is likely to be in the apoptotic phase (initial 
necrosis). The potential for n-hexane fraction of the 
rhizomes in stimulating cell apoptosis is probably 
caused by steroid terpenoids compounds n-hexane 
fraction. Terpenoids is compounds that have high 
anticancer activity that was tested through the ability 
to block nuclear factor-kappa B, induces apoptosis, 
activates transcription and angiogenesis, which can 
be useful in the treatment of various types of cancer 
[16], [17]. 
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